Increased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infection
- 1 December 1997
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 11 (15) , 1833-1838
- https://doi.org/10.1097/00002030-199715000-00007
Abstract
The β-chemokine receptor CCR-5 is used as a coreceptor by macrophage-tropic strains of HIV-1 to gain entry into CD4+ cells. To determine the effect of a common 32 base-pair deletion mutation in the CCR-5 gene (CCR-5 Δ32) on progression of HIV infection to AIDS, and to assess the level of heterozygosity for this mutation in a well-defined group of long-term non-progressors (LTNP). Sixty-four HIV-1-infected LTNP (CD4+ T lymphocyte count > 500 × 106/l after 8 years) were compared with 95 individuals infected within a similar period (1983–1986) but who had rapidly progressed to AIDS and death, and with a further 120 HIV-positive individuals with CD4+ counts < 500 × 106/l. The presence of the CCR-5 Δ32 mutation was assessed using polymerase chain reaction with primers spanning the 32 base-pair deletion. CD4+ and CD8+ counts, plasma HIV-1 RNA, p24 antigen and β2-microglobulin levels in LTNP carrying the CCR-5 Δ32 mutation were compared with LTNP lacking the mutation. A marked increase in the frequency of CCR-5 Δ32 heterozygosity was found among LTNP (35.9%) compared with rapid progressors (12.6%; P = 0.0005) and patients selected on the basis of a CD4+ T-cell count < 500 × 106/l (12.5%; P = 0.0004). LTNP heterozygous for CCR-5 Δ32 had a significantly higher CD8+ T-cell count than those without the mutation (1218 versus 972 × 106/l; P = 0.044). No significant correlation was observed between heterozygosity and CD4 count, viral load, p24 antigen or β2-microglobulin within the LTNP group. This study provides the strongest evidence to date for the importance of a single copy of the CCR-5 Δ32 mutation in long-term non-progression of HIV infection, which may involve, in part, CD8+ T lymphocytes. To determine the effect of a common 32 base-pair deletion mutation in the CCR-5gene (CCR-5 Δ32) on progression of HIV infection to AIDS, and to assess the level of heterozygosity for this mutation in a well-defined group of long-term non-progressors (LTNP).Keywords
This publication has 28 references indexed in Scilit:
- Exploiting the HIV-Chemokine NexusScience, 1997
- The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1Nature, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entryNature, 1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Serum chemokine levels in patients with non-progressing HIV infectionAIDS, 1996
- Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and RecipientsScience, 1995
- The immunology of primary HIV infection: which immune responses control HIV replication?Current Opinion in Immunology, 1995
- The Impact of the Syncytium-Inducing Phenotype of Human Immunodeficiency Virus on Disease ProgressionThe Journal of Infectious Diseases, 1994
- A Cross-Sectional Comparison of Persons with Syncytium- and Non-Syncytium-Inducing Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1993